Ciliary dysfunction linked to bronchopulmonary dysplasia severity in infants
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
23andMe will keep offering customers its DNA testing services after being bought out of bankruptcy. New York-based biotech company Regeneron...
A look at why the publicly traded pharmaceutical giant is snapping the genetic-testing company out of bankruptcy...Read More
Investigations over the last couple of decades have uncovered widespread fraud in the olive oil market, and because the FDA...
SAN DIEGO — A real-time, blood-sensing capsule (PillSense) is a safe and effective diagnostic tool for patients with suspected upper...
TOPLINE:Dermatology residency programs saw modest gains in racial and ethnic diversity from 2src2src to 2src24, but underrepresented groups remain disproportionately...
CHICAGO — Combining machine learning and patient-reported tools significantly improved early detection of dementia in primary care, according to new...
Changing the prescribing protocol for low-dose aspirin (LDA) for preeclampsia prevention from risk-based to universal significantly increased aspirin use in...
TORONTO — Older patients with axial spondyloarthritis (axSpA) are known to have a higher overall risk for cancer than the...
Drugmaker Regeneron Pharmaceuticals says it will comply with privacy policies regarding the use of customer data. 23andMe's bankruptcy filings had...
Regulator confirms safety and efficacy of new treatment option for patient The Medicines and Healthcare products Regulatory Agency (MHRA) has...
Biotech spin-off targets fibrosis, neoplasm and neovascularization Massalia Therapeutics, a biotechnology spin-off from the C2VN Institute, has officially launched with...
Using advanced artificial intelligence (AI), researchers have developed a novel method to make drug development faster and more efficient. In...
This vaccine did previously have emergency approval by the FDA for use but can now be marketed in the U.S....
If you’re among the one in three adults who struggles with seasonal allergies, the one in 10 dealing with some...
Please complete security verificationThis request seems a bit unusual, so we need to confirm that you're human. Please press and...
The FDA granted approval for use in adults 65 and older – or those 12 to 64 who have at...